April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Health State Questionnaires: What Do They Say About Low Vision Populations
Author Affiliations & Notes
  • J. E. Goldstein
    Ophthalmology, Johns Hopkins University, Baltimore, Maryland
  • K. D. Frick
    Health Services Research Division, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
  • R. W. Massof
    Ophthalmology, Johns Hopkins University, Baltimore, Maryland
  • Low Vision Research Network
    Ophthalmology, Johns Hopkins University, Baltimore, Maryland
  • Footnotes
    Commercial Relationships  J.E. Goldstein, None; K.D. Frick, Allergan, C; R.W. Massof, None.
  • Footnotes
    Support  EY012045
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 3211. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. E. Goldstein, K. D. Frick, R. W. Massof, Low Vision Research Network; Health State Questionnaires: What Do They Say About Low Vision Populations. Invest. Ophthalmol. Vis. Sci. 2009;50(13):3211.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the responsiveness of the EuroQoL (EQ-5D) to vision-related functional ability loss in patients seen in low vision clinics.

Methods: : Health state questionnaires including the EQ-5D, GDS, TICS, SF-36 and Activity Inventory (AI) were administered by telephone to 113 low vision patients across 15 clinical centers within the US. Patients ranged in age from 18-93 years with an average age of 74. Separate Rasch analyses were performed on patient responses to the GDS, SF-36 physical (SF-PHY), SF-36 psychological (SF¬-PSYCH), and AI. EQ-5D responses were transformed to full health utilities to generate the EQ-5D US index. Raw scores were used for the TICS and the SF-36 general health (SF-GH). The correlation matrix was analyzed with exploratory and then confirmatory factor analysis using a varimax rotation.

Results: : From confirmatory factor analysis, four independent factors were necessary and sufficient to explain 65% of variance. We provisionally identified these four factors as psychological(F1), physical(F2), cognitive(F3), and vision(F4). F1 explained 74% of the variance in the GDS measure, 62% in the SF-PSYCH, 16% in the SF-GH, and less than 2% in the TICS and AI. 12% of the variance in the EQ-5D is explained by F1. F2 explains 92% of the variance in the SF-PHY, 28% in the SF-GH, 7% in the SF-PSYCH, and 6% in the GDS. 2% or less of the variance in the TICS and AI load onto F2. 33% of the variance in the EQ-5D is explained by F2. F3 explains 34% of the variance in the TICS score, 8% in the GDS and 5% in the SF-PHY. Only 1% of the variance in the SF-GH and AI load onto F3. None of the variance in the EQ-5D or SF¬-PSYCH is explained by F3. F4 explains 97% of the variance in the AI. Only 2% of the variance in the EQ-5D and GDS could be explained by F4. Almost no variance in the SF¬-PSYCH, TICS and SF-GH loaded on to F4. For all factors, a similar pattern of loading is seen with the EQ-5D and SF-GH. Overall only 47% of the variance in the EQ-5D can be explained by the four factors.

Conclusions: : The variance in the EQ-5D does not load heavily on any one of the four factors identified for low vision patients, while most of the variance in the EQ-5D can be explained by the physical and psychological domains. With less than 2% of the variance explained by the vision factor, the EQ-5D is not an adequate measure of the functional consequences of visual impairment. TICS appears to be a well-aimed measure of the cognition factor but much of its variance remains unexplained. Of the four examined, only the vision factor contributes to AI measures.

Keywords: quality of life • low vision • clinical (human) or epidemiologic studies: outcomes/complications 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×